Intravitreal ranibizumab in the treatment of choroidal neovascularization associated with idiopathic central serous chorioretinopathy

European Journal of Ophthalmology

Volumn 20, Issue 5, 2010, Pages 955-958

  Konstantinidis, Lazaros ^a   Mantel, Irmela ^a   Zografos, Leonidas ^a   Ambresin, Aude ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Central serous chorioretinopathy; Choroidal neovascularization; Intravitreal ranibizumab

Indexed keywords

RANIBIZUMAB; DIAGNOSTIC AGENT; FLUORESCENT DYE; INDOCYANINE GREEN; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CASE REPORT; CENTRAL SEROUS RETINOPATHY; DISEASE ASSOCIATION; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; MEMBRANE PERMEABILITY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA MACULA LUTEA; RETROSPECTIVE STUDY; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; SWITZERLAND; VISUAL ACUITY; CHRONIC DISEASE; INJECTION; MIDDLE AGED; VITREOUS BODY;

AGED; ANTIBODIES, MONOCLONAL; CENTRAL SEROUS CHORIORETINOPATHY; CHOROIDAL NEOVASCULARIZATION; CHRONIC DISEASE; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT DYES; HUMANS; INDOCYANINE GREEN; INJECTIONS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; VITREOUS BODY;

EID: 77957603471     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067211002000524     Document Type: Article

References (6)

1. Loo RH, Scott IU, Flynn HW Jr, et al. Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina 2002; 22: 19-24.
2. Chan WM, Lai TY, Liu DT, Lam DS. Intravitreal bevacizumab (Avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin. Am J Ophthalmol 2007; 143: 977-83.
3. Cooper BA, Thomas MA. Submacular surgery to remove choroidal neovascularization associated with central serous chorioretinopathy. Am J Ophthalmol 2000; 130: 187-91.
4. Ergun E, Tittl M, Stur M. Photodynamic therapy with verteporfin in subfoveal choroidal neovascularization secondary to central serous chorioretinopathy. Arch Ophthalmol 2004; 122: 37-41.
5. Prunte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996; 121: 26-34.
6. Schaal KB, Hoeh AE, Scheuerle A, Schuett F, Dithmar S. Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy. Eur J Ophthalmol 2009; 19: 613-7.